Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive, Suite 106,
Hanover, Maryland 21076
September 25, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, D.C. 20549
Attention: Mr. Tim Buchmiller
Re: | Processa Pharmaceuticals, Inc. | |
Withdrawal of Form RW Related to Registration Statement on Form S-1 (Registration No. 333-235511) |
Ladies and Gentlemen:
Reference is made to the Form RW filed on September 25, 2020 by Processa Pharmaceuticals, Inc. (the “Company”) related to its Registration Statement on Form S-1 (Registration No. 333-235511) (the “Form RW”). The Form RW was inadvertently filed and was intended to be filed as correspondence to withdraw a prior acceleration request. Accordingly, the Company respectfully withdraws the Form RW-Registration Withdrawal Request.
The Registrant respectfully requests that you contact Michael Kirwan of Foley & Lardner LLP by telephone call to (904) 633-8913 with any questions or requests for additional information.
Very truly yours, | ||
Processa Pharmaceuticals, Inc. | ||
By: | /s/ David Young | |
David Young, Pharm.D., Ph.D. | ||
Chief Executive Officer |